6 authorised products containing Rivastigmine, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Exelon 13.3 mg/24 h transdermal patch EU/1/98/066/027-030 |
Rivastigmine | Novartis Europharm Limited | — |
| Exelon 4.6 mg/24 h transdermal patch EU/1/98/066/19-22 |
Rivastigmine | Novartis Europharm Limited | — |
| Exelon 9.5 mg/24 h transdermal patch EU/1/98/066/23-26 |
Rivastigmine | Novartis Europharm Limited | — |
| Prometax 13.3 mg/24 h transdermal patch EU/1/98/092/027-030 |
Rivastigmine | Almirall, S.A. | — |
| Prometax 4.6 mg/24 h transdermal patch EU/1/98/092/19-22 |
Rivastigmine | Almirall, S.A. | — |
| Prometax 9.5 mg/24 h transdermal patch EU/1/98/092/23-26 |
Rivastigmine | Almirall, S.A. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.